Availability
0
Your Basket is Empty
FQ02772

R-(-)-3-Quinuclidinol

Synthon for preparation of cholinergic receptor ligands; hypotensive

Technical Data

CAS No: 25333-42-0
Synonyms: (R)-(-)-3-Hydroxyquinuclidine; (R)-(-)-1-Azabicyclo[2.2.2]octan-3-ol; Solifenacin EP Impurity E
Product Code: FQ02772
MDL No: MFCD13191732
Chemical Formula: C7H13NO
Molecular Weight: 127.18

References


  • Basavaiah, D et al (1996). The Baylis-Hillman reaction: A novel carbon-carbon bond forming reaction. Tetrahedron 52(24): 8001-8062., Shang, Y et al (2009). Novel Sc(OTf)3/3-HQD Catalyst for Morita–Baylis–Hillman Reaction. Synth Commun 39(6): 10335-1045.
  • Drewes, SE and Roos GHP (1988). Synthetic potential of the tertiary-amine-catalysed reaction of activated vinyl carbanions with aldehydes. Tetrahedron 44(15):4653-4670., Sterling, GH et al (1993). 3-Carbamyl-N-allylquinuclidinium bromide. Effects on cholinergic activity and protection against soman. Biochem Pharmacol 45(2):465-72.
  • Häring D anad Schreier P (1999). Cross-linked enzyme crystals. Curr Opin Chem Biol 3(1):35-38., Ticehurst, MD et al (2000). Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide. Int J Pharm 193(2):247-59.
  • Leusch, A et al (2000). Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to man. Xenobiotica 30(8): 797-8013., Wallan, A et al (1997). In vivo consequences of M1-receptor activation by talsaclidine. Life Sci 60(13-14): 977-984.
  • Reiner, E et al (1999). 3-Hydroxyquinuclidinium derivatives: synthesis of compounds and inhibition of acetylcholinesterase. Chem Biol Interact 119-120:173-81.

Solubility

Stability

Further Information


Datasheets

Specification: View
MSDS: View
Technical Bulletin: View

R-(-)-3-Quinuclidinol

CAS No:
25333-42-0
Synonyms:
(R)-(-)-3-Hydroxyquinuclidine
(R)-(-)-1-Azabicyclo[2.2.2]octan-3-ol
Solifenacin EP Impurity E
MDL No:
MFCD13191732
Chemical Formula:
Molecular Weight:
127.18
Product Structure
References:
1. Basavaiah, D et al (1996). The Baylis-Hillman reaction: A novel carbon-carbon bond forming reaction. Tetrahedron 52(24): 8001-8062.,
Shang, Y et al (2009). Novel Sc(OTf)3/3-HQD Catalyst for Morita–Baylis–Hillman Reaction. Synth Commun 39(6): 10335-1045.
2. Drewes, SE and Roos GHP (1988). Synthetic potential of the tertiary-amine-catalysed reaction of activated vinyl carbanions with aldehydes. Tetrahedron 44(15):4653-4670., Sterling, GH et al (1993). 3-Carbamyl-N-allylquinuclidinium bromide. Effects on cholinergic activity and protection against soman. Biochem Pharmacol 45(2):465-72.
3. Häring D anad Schreier P (1999). Cross-linked enzyme crystals. Curr Opin Chem Biol 3(1):35-38., Ticehurst, MD et al (2000). Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide. Int J Pharm 193(2):247-59.
4. Leusch, A et al (2000). Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to man. Xenobiotica 30(8): 797-8013., Wallan, A et al (1997). In vivo consequences of M1-receptor activation by talsaclidine. Life Sci 60(13-14): 977-984.
5. Reiner, E et al (1999). 3-Hydroxyquinuclidinium derivatives: synthesis of compounds and inhibition of acetylcholinesterase. Chem Biol Interact 119-120:173-81.
Click for Specification
Click for MSDS
Click for Technical Bulletin

Scale Available 100’s kgs

For requirements greater than the catalogue prepacks email: enquiries@carbosynth.com

Custom Synthesis

For custom synthesis or special requests email: enquiries@carbosynth.com, call +44 (0)1635 578444 or fill out our contact form

Please Wait...